Status:

TERMINATED

Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity

Lead Sponsor:

Montefiore Medical Center

Conditions:

Chronic Allograft Injury

Calcineurin Inhibitor Toxicity

Eligibility:

All Genders

Phase:

NA

Brief Summary

The purpose of this study is to find out how well the current drug regimen (including low Prograf dose and Myfortic, which is usually recommended to prevent any further deterioration in the kidney fun...

Detailed Description

Specific Aim 1: To investigate allograft and peripheral blood cell gene expression patterns of patients with CAI by using Affymetrix microarrays. Hypothesis 1: Gene expression patterns of patients wi...

Eligibility Criteria

Inclusion

  • All patients with biopsy proven pure chronic allograft injury due to CNI toxicity.

Exclusion

  • 24 hour urine protein or spot urine protein/creatinine ratio \> 500 mg/day
  • Estimated glomerular filtration rate (eGFR) \< 30 ml/min by modification of Diet in Renal Disease( MDRD) or 24 hour urine collection
  • Patients with Donor-specific antibody (DSA) by Luminex (mean fluorescence intensity values \> 1,000)
  • Recipients of multiple organ transplants or ABO-incompatible allograft
  • Current panel reactive antibody (PRA) greater than 30 percent
  • Graft loss at randomization
  • Pregnant women
  • Previous history of acute rejection
  • Previous history of allergy or intolerance to Zortress or Myfortic
  • Platelet count less than 100,000
  • White Blood Cell (WBC) less than 3,000
  • Hb less than 9 g/dL or Htc less than 30%
  • Biopsy findings of
  • Chronic antibody mediated rejection
  • Acute rejection
  • Positive C4d staining
  • Interstitial infiltrates more than 25% of the area
  • Transplant glomerulopathy
  • Recurrent or de novo glomerular disease
  • Polyoma nephropathy or positive simian virus 40 (SV40) staining

Key Trial Info

Start Date :

March 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT01473732

Start Date

March 1 2012

End Date

August 1 2012

Last Update

October 16 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Montefiore Medical Center

The Bronx, New York, United States, 10467

Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity | DecenTrialz